Revvity (RVTY) Gains from Investment Securities (2016 - 2026)
Revvity's (RVTY) quarterly Gains from Investment Securities came in at $1.6 million in Q3 2026, up 254.25% on a YoY basis from $459000.0 in Q3 2025, and up 1742.42% quarter-over-quarter from -$99000.0 in Q2 2026.
Powered by 
Analysis
Revvity (RVTY) Gains from Investment Securities (2016 - 2026) Analysis & Trends
Revvity (RVTY) has reported Gains from Investment Securities for 11 consecutive years, with $1.6 million the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Gains from Investment Securities rose 254.25% year-over-year to $1.6 million; the trailing twelve-month figure through Jul 2026 stood at $293000.0 (up 103.49% YoY), and the FY2025 full-year result was -$1.4 million, up 25.09% from the prior year.
- Gains from Investment Securities climbed to $1.6 million in Q3 2026 per RVTY's latest filing, from -$99000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $6.2 million in Q1 2024 and bottomed at -$7.9 million in Q4 2024.
- Historically, Gains from Investment Securities has averaged $11812.5 across 5 years, with a median of $141500.0 in 2024.
- The widest YoY moves for Gains from Investment Securities: up 553.9% in 2024, down 421.43% in 2024.
- Over 5 years, Gains from Investment Securities stood at $693000.0 in 2022, then soared by 253.54% to $2.4 million in 2023, then slumped by 421.43% to -$7.9 million in 2024, then soared by 82.97% to -$1.3 million in 2025, then surged by 221.25% to $1.6 million in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $1.6 million, -$99000.0, and -$1.3 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 1.63 Mn |
| Apr 5, 2026 | -99,000.00 |
| Dec 28, 2025 | -1.34 Mn |
| Sep 28, 2025 | 107,000.00 |
| Jun 29, 2025 | 459,000.00 |
| Mar 30, 2025 | -625,000.00 |
| Dec 29, 2024 | -7.88 Mn |
| Sep 29, 2024 | -343,000.00 |
| Jun 30, 2024 | 176,000.00 |
| Mar 31, 2024 | 6.17 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Oct 1, 2023 | 633,000.00 |
| Jul 2, 2023 | 2.45 Mn |
| Apr 2, 2023 | -1.36 Mn |
| Jan 1, 2023 | -2.93 Mn |
| Apr 3, 2022 | 693,000.00 |
| Oct 3, 2021 | 1.08 Mn |
| Jul 4, 2021 | 237,000.00 |
| Apr 4, 2021 | 240,000.00 |
| Jan 3, 2021 | -20,000.00 |